Conduit Pharmaceuticals Inc [NASDAQ: CDT] loss -10.53% on the last trading session, reaching $0.17 price per share at the time.
If compared to the average trading volume of 9.28M shares, CDT reached a trading volume of 13811556 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Trading performance analysis for CDT stock
Conduit Pharmaceuticals Inc [CDT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.61. With this latest performance, CDT shares dropped by -35.24% in over the last four-week period, additionally sinking by -93.82% over the last 6 months – not to mention a drop of -98.43% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CDT stock in for the last two-week period is set at 17.99, with the RSI for the last a single of trading hit 22.70, and the three-weeks RSI is set at 19.12 for Conduit Pharmaceuticals Inc [CDT]. The present Moving Average for the last 50 days of trading for this stock 1.0101, while it was recorded at 0.1756 for the last single week of trading, and 2.6406 for the last 200 days.
Conduit Pharmaceuticals Inc [CDT]: A deeper dive into fundamental analysis
Conduit Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.59 and a Current Ratio set at 1.59.
An analysis of Institutional ownership at Conduit Pharmaceuticals Inc [CDT]
The top three institutional holders of CDT stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in CDT stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in CDT stock with ownership which is approximately 5.1238%.
